GT Medical Technologies Announces the Presentation of Clinical Data on GammaTile® Therapy in the Treatment of Recurrent Glioblastomas at the 2022 American Association of Neurological Surgeons Scientific Meeting

GT Medical Technologies, Inc. announced today that new data on the company’s innovative GammaTile Therapy for patients with operable brain tumors will be presented via an oral, live presentation at the 2022 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Philadelphia, PA. The abstract will provide the first report of clinical outcomes for recurrent glioblastoma patients treated with FDA-cleared GammaTile Therapy.

Novel Therapy Uses Radioactive Seeds to Treat Brain Tumors

A diagnosis of cancer is shocking for most people. But a diagnosis of brain cancer may carry additional fear when one considers these facts: no other cancer is as challenging to effectively treat as brain cancer, and the average five-year survival rate for people with malignant brain tumors is about 36%.

Fortunately, the availability of a novel treatment called GammaTile® Therapy is offering hope for people like 68-year-old Jane Finch Hall.

GammaTile Is the New Frontier for Radiation Treatment

Mayfield Brain & Spine’s Vincent DiNapoli, M.D., Ph.D. was the first surgeon in the eastern U.S. to perform surgery on recurrent brain tumors using a new radiation delivery technique called GammaTile Therapy. Now, he’s partnered with Oncology Hematology Care and Jewish Hospital – Mercy Health (where he’s also the director of the Brain Tumor Center) for a new study using GammaTile to treat newly diagnosed primary cancer that’s moved to the brain. DiNapoli explains how the treatment works.

GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas

Neuro-Oncology Advances 2021 | Dominic J Gessler, Elizabeth C Neil, Rena Shah, Joseph Levine, James Shanks, Christopher Wilke, Margaret Reynolds, Shunqing Zhang, Can Özütemiz, Mehmet Gencturk, Mark Folkertsma, W Robert Bell, Liam Chen, Clara Ferreira, Kathryn Dusenbery, Clark C Chen. GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas [published online December 27, 2021]. https://doi.org/10.1093/noajnl/vdab185